Get the Stockscreener App
0.4656
1.98%
-0.0094
After Hours:
.47
0.0044
+0.95%
Klotho Neurosciences Inc stock is traded at $0.4656, with a volume of 275.69K.
It is down -1.98% in the last 24 hours and down -24.76% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.475
Open:
$0.46
24h Volume:
275.69K
Relative Volume:
0.15
Market Cap:
$28.58M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-1.0224
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
-0.51%
1M Performance:
-24.76%
6M Performance:
+61.00%
1Y Performance:
+69.31%
1-Day Range:
$0.45
$0.4879
1-Week Range:
$0.45
$0.56
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.4656 | 29.15M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Will Klotho Neurosciences Inc. Equity Warrant continue its uptrendWeekly Investment Recap & Intraday High Probability Setup Alerts - newser.com
Klotho Neurosciences Inc. Equity Warrant’s volatility index tracking explained2025 Performance Recap & AI Driven Stock Reports - newser.com
What to expect from Klotho Neurosciences Inc. in the next 30 days2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
How institutional buying supports Klotho Neurosciences Inc. Equity Warrant stockMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com
What technical models suggest about Klotho Neurosciences Inc. Equity Warrant’s comebackMarket Performance Recap & Reliable Price Breakout Alerts - newser.com
Is Klotho Neurosciences Inc. Equity Warrant showing signs of accumulationM&A Rumor & Community Trade Idea Sharing Platform - newser.com
Is Klotho Neurosciences Inc. stock ready for a breakoutTrade Volume Summary & Growth Focused Stock Reports - newser.com
Klotho Neurosciences, Inc. SEC 10-Q Report - TradingView
Will Klotho Neurosciences Inc. Equity Warrant stock sustain high P E ratiosAnalyst Downgrade & Fast Entry and Exit Trade Plans - newser.com
Can you recover from losses in Klotho Neurosciences Inc.2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Is MPTIWS a good long term investmentStock Market Trends & Free Trading Psychology Coaching - earlytimes.in
What indicators show strength in Klotho Neurosciences Inc. Equity WarrantWeekly Profit Report & Fast Gain Stock Tips - newser.com
Price momentum metrics for Klotho Neurosciences Inc. explained2025 Support & Resistance & Safe Entry Trade Signal Reports - newser.com
Should You Watch Bhilwara Technical Textiles Limited for Sector Rotation UpsideContrarian Investment Ideas & Free Rapid Portfolio Appreciation - earlytimes.in
How to interpret RSI for Klotho Neurosciences Inc. stockWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
Is Klotho Neurosciences Inc. stock a safe investment in uncertain marketsTrade Volume Summary & Weekly High Momentum Picks - newser.com
Is Klotho Neurosciences Inc. Equity Warrant stock attractive after correctionJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
Is now a turning point for Klotho Neurosciences Inc.Trade Risk Report & Fast Entry High Yield Stock Tips - newser.com
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award - Lelezard
Why Klotho Neurosciences Inc. stock remains on watchlistsJuly 2025 Technicals & Daily Stock Trend Reports - Fundação Cultural do Pará
Why Klotho Neurosciences Inc. stock remains a top recommendationMarket Movers & AI Enhanced Market Trend Forecasts - Fundação Cultural do Pará
Is Klotho Neurosciences Inc. stock overvalued by current metrics2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
Can Klotho Neurosciences Inc. stock attract ESG capital inflowsJuly 2025 Catalysts & Weekly Breakout Watchlists - Fundação Cultural do Pará
Is Klotho Neurosciences Inc. stock supported by strong fundamentalsQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Will a bounce in Klotho Neurosciences Inc. Equity Warrant offer an exitQuarterly Portfolio Report & High Accuracy Buy Signal Tips - newser.com
Building trade automation scripts for Klotho Neurosciences Inc. Equity WarrantWeekly Risk Report & Consistent Profit Alerts - newser.com
Is Klotho Neurosciences Inc. Equity Warrant stock supported by strong cash flowsJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Will Klotho Neurosciences Inc. stock split attract more investors2025 Support & Resistance & AI Enhanced Execution Alerts - Fundação Cultural do Pará
Published on: 2025-11-05 20:42:33 - Fundação Cultural do Pará
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):